Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
And this year, we’re continuing the journey with our 2026 list of 100 Influential Women in Oncology, showcasing the remarkable efforts made by these inspiring women across the world to improve cancer care.
There are so many incredible women in oncology whose work deserves to be seen and celebrated, and we know that one list can never include everyone. This is an ongoing initiative, and we’d love to hear your suggestions for the 100 Influential Women in Oncology in 2026 list. We’ll be sharing the nomination link soon.
We are proud to introduce the last 10 women featured in our 2026 list of 100 Influential Women in Oncology:
Olivia Munn
Olivia Munn is an actress and breast cancer advocate who publicly shared in 2024 that she had been diagnosed the previous year with stage I, hormone receptor-positive, HER2-negative luminal B breast cancer in both breasts. Since then, Munn has used her platform to advocate for individualized breast cancer risk assessment, earlier detection, and greater awareness that negative genetic testing does not mean low risk. In November 2026, she joined U.S. Senator Mark Kelly on Capitol Hill to introduce the bipartisan, bicameral Know Your Risk Act, which she helped develop and which aims to make evidence-based breast cancer risk assessment a routine part of healthcare.
Alessandra Moretti

Alessandra Moretti is an Italian Member of the European Parliament, currently serving as Co-Chair of the European Parliament Intergroup on Cancer and Rare Diseases and as a member of the Parliament’s Committee on Public Health (SANT). A former member of the European Parliament’s Special Committee on Beating Cancer, she was also appointed S&D shadow rapporteur for the 2025–2026 review of Europe’s Beating Cancer Plan, helping shape Parliament’s position on prevention, early detection, treatment, survivorship, inequalities, and future financing of cancer control across the EU.
Katherine Van Loon

Katherine Van Loon, MD, MPH, FASCO, is a gastrointestinal oncologist, Director of the Global Cancer Program at UCSF, and Editor-in-Chief of JCO Global Oncology. She has led longstanding collaborations in Tanzania investigating environmental, genetic, and molecular drivers of esophageal cancer, while helping train researchers and strengthen cancer research infrastructure globally. In 2026, she received ASCO’s Hologic, Inc. Endowed Women Who Conquer Cancer Mentorship Award, recognizing her commitment to mentoring the next generation of cancer researchers and global oncology leaders.
Dean Crowe

Dean Crowe is the founder and CEO of Rally Foundation for Childhood Cancer Research, which she launched in 2005 to accelerate better treatments and cures for childhood cancers. Under her leadership, Rally has awarded more than $47.5 million in research grants and helped leverage over $1 billion in additional funding for pediatric cancer research. Crowe has also become a major policy advocate, helping secure federal funding for cancers affecting children, adolescents, and young adults and supporting landmark 2026 legislation expanding pediatric cancer research, data initiatives, and access to care.
Annalice Gandini

Annalice Gandini, MD, is a gastrointestinal medical oncologist and Clinical Fellow at Hôpital Européen Georges-Pompidou in Paris, with research focused on colorectal cancer, particularly early-onset disease, ctDNA, precision oncology, and immunotherapy. In 2026, she led research examining molecular features of colorectal cancer and real-world treatment strategies, while also founding and leading YOGI-EU (Young Oncologists in GI, Europe), a pan-European network created to connect and support the next generation of GI oncologists.
Lore Gruenbaum

Lore Gruenbaum, PhD is the Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, where she oversees the organization’s biomedical research strategy, grant portfolio, Beat AML Master Clinical Trial, and Therapy Acceleration Program. With more than two decades of experience across biotech and pharma, she has helped advance more than 20 drug candidates into clinical trials and contributed to three FDA-approved medicines. Her work now focuses on using venture philanthropy, collaborative trials, and strategic research investment to accelerate new therapies for blood cancers.
Muna Al-Khaifi

Muna Al-Khaifi, MD, CCFP, MPH, is a Canadian GP oncologist and women’s health specialist whose work focuses on breast cancer survivorship, onco-menopause, sexual health, and quality of life after cancer. She has led breast cancer survivorship care at Sunnybrook and currently works across breast diagnostics and survivorship programs in Toronto, while also co-chairing Ontario Health’s Cancer Survivorship Quality Standard advisory committee. In 2026, with her survivorship series on OncoDaily she continues to advocate for closing major gaps in survivorship care, including the persistent under-recognition of female sexual health after cancer treatment.
Debra Patt

Debra Patt, MD, PhD, MBA, FASCO, is a breast oncologist, President of the Community Oncology Alliance, Executive Vice President at Texas Oncology, and a member of the ASCO Board of Directors. A national leader in cancer policy and community oncology, she has testified before the U.S. Congress and Senate on access to cancer care and serves as Medical Director for Public Policy for The US Oncology Network. She is also a leading voice on digital transformation and artificial intelligence in oncology, including chairing ASCO’s AI Task Force.
The last group of 10 women featured in OncoDaily’s 100 Influential Women in Oncology 2026 brought together another group of remarkable women making a difference across the field of oncology. We will continue next year, sharing more stories of women whose work is making a difference in oncology around the world.
Don’t miss the previous parts of 100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond.
Watch on OncoDaily TV.
More from OncoDaily 100:

